Katarina Pance

Katarina Pance, PhD, is a Senior Associate and investment professional at SR One Capital Management, a leading venture capital firm focused on life sciences. At SR One, she plays an integral role in sourcing, evaluating, and managing investments in innovative biopharmaceutical and biotechnology companies, with a specific emphasis on antibody therapeutics and targeted protein degradation. She is actively involved in company governance, currently serving on the boards of Veradermics, Palleon Pharmaceuticals, and Topo Therapeutics.

Dr. Pance's expertise centers on early- and late-stage investments in the biopharmaceutical sector, particularly companies developing novel therapeutics and platform technologies. Her board involvement with Veradermics highlights her active engagement in advancing therapies for dermatologic and aesthetic conditions, leveraging her deep scientific knowledge to guide portfolio companies through critical inflection points in clinical and commercial development.

She holds a PhD in Chemistry and Chemical Biology from the University of California, San Francisco, and a bachelor's degree in Biochemistry (with minors in History and Chemistry) from the University of Pennsylvania. Before joining SR One in 2023, Dr. Pance co-founded and worked at EpiBiologics, further establishing her credentials in antibody therapeutic development and targeted modalities in biotech investing.